Diabetes therapy - Strategic Insights Report (Page 2)

Diabetes therapy

Intestinal Fructose Metabolism Triggers Glucagon-Like Peptide-1-β-Cell Axis to Prevent Post-Fructose Hyperglycemia

Researchers from Fujita Health University have made a significant discovery in the field of nutritional and metabolic diseases. According to a news report, the team found that fructose ingestion increases circulating glucagon-like peptide-1 (GLP-1) and insulin, which helps to counteract fructose-induced hyperglycemia. The study, published in The Journal of Physiology,

Diabetes therapy

Workplace Culture of Health and Diabetes Self-Management Behaviors in Urban China

A new study has shed light on the relationship between workplace culture of health and diabetes self-management behaviors among employees with type 2 diabetes in urban China. The research, conducted by investigators at Shanxi Medical University, recruited 462 employees with type 2 diabetes from three tertiary hospitals in Taiyuan City,

Diabetes therapy

Limited Time and Resources Hinder Patient Counseling on Continuous Glucose Monitors

Research has shown that community pharmacists face challenges in providing effective patient education on continuous glucose monitors (CGMs), which are crucial for diabetes management. According to a recent study, limited time and resources may result in inadequate or absent counseling, potentially impacting the accuracy and accessibility of CGM use. Key

Adults

Factors Influencing Type 2 Diabetes in Adults Revealed by Zhejiang Provincial Center for Disease Control and Prevention Study

A recent study published in Frontiers in Public Health has shed light on the factors influencing type 2 diabetes mellitus (T2DM) among adults in Zhejiang Province, China. The study employed a stratified cluster sampling technique, involving 5,804 adults without known diabetes, and assessed various factors including food consumption, blood

Diabetes therapy

GLP-1 Receptor Polymorphism Alters Efficacy of Liraglutide Treatment in Individuals with Obesity

Researchers at Vanderbilt University Medical Center have identified a genetic variant in the glucagon-like peptide-1 receptor (GLP-1R) that influences the effectiveness of liraglutide, a medication used to treat obesity and pre-diabetes. The study, published in the Journal of Endocrinology, found that individuals with the variant allele (rs6923761) experienced greater weight

Corporate culture

Workplace Culture of Health and Diabetes Self-Management Behaviors in Urban China

Anti-obesity agents

New Research on Liver Diseases and Conditions Reveals Promise of Glucagon-Like Peptide-1 Receptor Agonists

Investigators at Rutgers University - The State University of New Jersey have conducted new research on liver diseases and conditions, highlighting the potential of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in managing metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH). The study, published in Clinics

Diabetes therapy

Nurse-Led Interventions Improve Self-Management Behaviours and Self-Efficacy in Individuals with Type 2 Diabetes

A systematic review and meta-analysis conducted by researchers from Beihua University found that nurse-led interventions significantly improved self-management behaviours and self-efficacy in individuals with type 2 diabetes mellitus. The study, published in the International Journal of Nursing Practice, aimed to evaluate the effectiveness of nurse-led self-management interventions on self-management behaviours

Diabetes therapy

Intestinal Fructose Metabolism Triggers Glucagon-Like Peptide-1-β-Cell Axis to Prevent Post-Fructose Hyperglycemia

Diabetes therapy

GLP-1 Receptor Agonist Therapy Offers Cardiovascular and Renal Benefits in Type 2 Diabetes Patients Aged 80 and Older

Research conducted at the Shin Kong Wu Ho-Su Memorial Hospital in Taipei, Taiwan, has demonstrated the efficacy of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in improving glycemic control and reducing adverse outcomes in patients with type 2 diabetes mellitus (T2DM) aged 80 and older. The study, published in the Journal

Corporate culture

Workplace Culture of Health and Diabetes Self-Management Behaviors in Urban China

Diabetes therapy

Nurse-Led Interventions Improve Self-Management Behaviours and Self-Efficacy in Individuals with Type 2 Diabetes

See all